Closed Loop Medicine

Closed Loop Medicine is the global leader in the development of single prescription drug plus digital therapy (DTx) combination products developed to optimise dosing on an individual level with linked behaviour therapy to improve patient outcomes. The company was founded by an experienced team of healthcare professionals, entrepreneurs and life scientists with experience of both drug and software development, as well as extensive health system innovation experience. The company has two products in development for hypertension and insomnia. It has further products in its pipeline for a wide portfolio of chronic diseases. The Company ensures that both patient and clinician are at the centre of its products design and development.

Closed Loop Medicine headquartered in Europe, operates in the Health Care, Pharmaceutical, Therapeutics sector. The company focuses on Health Care and has secured $1.7B in funding across 72 round(s). With a team of 11-50 employees, Closed Loop Medicine is actively contributing to advancements in Health Care. Their latest funding round, Seed Round - Closed Loop Medicine, raised $17.8M. Discover more about their projects, partnerships, and impact on our platform.